BioGaia AB (BGLAF)
11.55
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
BioGaia EPS Diluted (Quarterly) : 0.1089 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1089 |
| March 31, 2026 | 0.0859 |
| December 31, 2025 | 0.1038 |
| September 30, 2025 | 0.0684 |
| June 30, 2025 | 0.0899 |
| March 31, 2025 | 0.0743 |
| December 31, 2024 | 0.0751 |
| September 30, 2024 | 0.0347 |
| June 30, 2024 | 0.1028 |
| March 31, 2024 | 0.1161 |
| December 31, 2023 | 0.0625 |
| September 30, 2023 | 0.093 |
| June 30, 2023 | 0.0757 |
| March 31, 2023 | 0.11 |
| December 31, 2022 | 0.1286 |
| September 30, 2022 | 0.0746 |
| June 30, 2022 | 0.079 |
| March 31, 2022 | 0.0809 |
| December 31, 2021 | 0.0428 |
| September 30, 2021 | 0.0605 |
| June 30, 2021 | 0.0644 |
| March 31, 2021 | 0.0594 |
| December 31, 2020 | 0.047 |
| September 30, 2020 | 0.0266 |
| June 30, 2020 | 0.0942 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0497 |
| December 31, 2019 | 0.0611 |
| September 30, 2019 | 0.0458 |
| June 30, 2019 | 0.0746 |
| March 31, 2019 | 0.0449 |
| December 31, 2018 | 0.0728 |
| September 30, 2018 | 0.0664 |
| June 30, 2018 | 0.0834 |
| March 31, 2018 | 0.0614 |
| December 31, 2017 | 0.0671 |
| September 30, 2017 | 0.0597 |
| June 30, 2017 | 0.0618 |
| March 31, 2017 | 0.0554 |
| December 31, 2016 | 0.0599 |
| September 30, 2016 | 0.0474 |
| June 30, 2016 | 0.054 |
| March 31, 2016 | 0.0461 |
| December 31, 2015 | 0.0297 |
| September 30, 2015 | 0.028 |
| June 30, 2015 | 0.049 |
| March 31, 2015 | 0.0599 |
| December 31, 2014 | 0.028 |
| September 30, 2014 | 0.0242 |
| June 30, 2014 | 0.0312 |
| March 31, 2014 | 0.1742 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hansa Biopharma AB | -0.279 |
| BioArctic AB | -0.0134 |
| Swedish Orphan Biovitrum AB | 0.1673 |
| Diamyd Medical AB | -0.0909 |
| BONESUPPORT HOLDING AB | 0.1309 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.02M |
| Revenue (Quarterly) | 47.08M |
| Total Expenses (Quarterly) | 36.06M |
| Enterprise Value | 1.122B |
| Gross Profit Margin (Quarterly) | 72.79% |
| Profit Margin (Quarterly) | 23.40% |
| Earnings Yield | 3.18% |
| Operating Earnings Yield | 4.00% |
| Normalized Earnings Yield | 3.192 |